![Atomazul | Adobe Stock](/remote/aHR0cHM6Ly9naWVjZG4uYmxvYi5jb3JlLndpbmRvd3MubmV0L2ZpbGV1cGxvYWRzL2ltYWdlLzIwMjAvMTEvMTIvbWVkaWNhbG1hcmlqdWFuYWlucnhib3R0bGUtYWRvYmVzdG9jay1jcmVkaXQtYXRvbWF6dWwtcmVzaXplZC5qcGc.LQuEqRfwW94.jpg?w=948&h=533&format=webp&mode=pad&anchor=middlecenter&scale=both&bgcolor=F0F1F2)
Atomazul | Adobe Stock
The Pennsylvania Medical Marijuana Advisory Board held a quarterly meeting Nov. 10, where it rejected adding insomnia to the state’s list of qualifying conditions, according to a TribLive.com report.
The board voted 7-4 to reject insomnia as a new qualifying condition, and tabled a discussion on whether to add traumatic brain injuries to the list, the news outlet reported.
There are more than 460,000 Pennsylvanians currently enrolled in the state’s medical cannabis program, according to TribLive.com, and while there are currently 23 qualifying conditions, the vast majority of patients qualify under anxiety disorders, chronic pain and post-traumatic stress disorder (PTSD).
The public can apply for new conditions to be added to the list, and the Medical Marijuana Advisory Board considers the applications and makes recommendations, although Pennsylvania Health Secretary Rachel Levine makes the final decision on which conditions make the list, TribLive.com reported.
Latest from Cannabis Business Times
- USC Athletics, Cookies Announce Trailblazing CBD Partnership for College Football, Basketball Sponsorship
- Trulieve Set to Open Medical Cannabis Dispensary in Clearwater
- Kentucky’s Medical Cannabis Program Attracts 5K License Applicants
- AYR Wellness Awarded Virginia’s HSA I Vertical Cannabis License
- Navigating the Green Line: How to Balance Selling and Profitability in Cannabis Retail
- DCC’s ‘Inadequate Oversight’ of $100M Undermined California Licensing Program for Cannabis Growers
- High Tide to Open Canna Cabana Store in Lucan, Ontario
- Whitney Economics Reduces 2030 Hemp Fiber and Grain Acreage Forecast by 4.5 Million Acres